Bill
S 5059
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
119th Congress
Introduced by Angela Alsobrooks and 3 co-sponsors
The bill would streamline FDA biosimilar review under the Public Health Service Act, potentially shortening timelines and easing regulatory hurdles for approval.
Introduced in Senate